158 related articles for article (PubMed ID: 16255151)
1. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
[TBL] [Abstract][Full Text] [Related]
2. When temozolomide alone fails: adding procarbazine in salvage therapy of glioma.
Huang F; Kavan P; Guiot MC; Markovic Y; Roberge D
Can J Neurol Sci; 2008 May; 35(2):192-7. PubMed ID: 18574933
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
Narita Y
Prog Neurol Surg; 2018; 31():145-151. PubMed ID: 29393182
[TBL] [Abstract][Full Text] [Related]
4. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
5. Low-grade gliomas.
Ruiz J; Lesser GJ
Curr Treat Options Oncol; 2009 Aug; 10(3-4):231-42. PubMed ID: 19381819
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary management of adult low grade gliomas.
Mariş D; Nica D; Mohan D; Moisa H; Ciurea AV
Chirurgia (Bucur); 2014; 109(5):590-9. PubMed ID: 25375042
[TBL] [Abstract][Full Text] [Related]
7. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
[TBL] [Abstract][Full Text] [Related]
8. Prospective clinical trials of intracranial low-grade glioma in adults and children.
Shaw EG; Wisoff JH
Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
[TBL] [Abstract][Full Text] [Related]
9. Low-grade gliomas.
Schiff D
Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
[TBL] [Abstract][Full Text] [Related]
10. Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.
Ollier E; Mazzocco P; Ricard D; Kaloshi G; Idbaih A; Alentorn A; Psimaras D; Honnorat J; Delattre JY; Grenier E; Ducray F; Samson A
Fundam Clin Pharmacol; 2017 Jun; 31(3):347-358. PubMed ID: 27933657
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D
Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
[TBL] [Abstract][Full Text] [Related]
12. The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.
Ziu M; Kalkanis SN; Gilbert M; Ryken TC; Olson JJ
J Neurooncol; 2015 Dec; 125(3):585-607. PubMed ID: 26530261
[TBL] [Abstract][Full Text] [Related]
13. Evolving management of low grade glioma: No consensus amongst treating clinicians.
Field KM; Rosenthal MA; Khasraw M; Sawkins K; Nowak AK
J Clin Neurosci; 2016 Jan; 23():81-87. PubMed ID: 26601811
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Nahed BV; Redjal N; Brat DJ; Chi AS; Oh K; Batchelor TT; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):609-30. PubMed ID: 26530264
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the use of chemotherapy in brain tumours.
van den Bent MJ; Hegi ME; Stupp R
Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in low-grade gliomas.
Viaccoz A; Lekoubou A; Ducray F
Curr Opin Oncol; 2012 Nov; 24(6):694-701. PubMed ID: 22913972
[TBL] [Abstract][Full Text] [Related]
17. Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?
Laack NN; Sarkaria JN; Buckner JC
Semin Radiat Oncol; 2015 Jul; 25(3):197-202. PubMed ID: 26050590
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.
Pace A; Vidiri A; Galiè E; Carosi M; Telera S; Cianciulli AM; Canalini P; Giannarelli D; Jandolo B; Carapella CM
Ann Oncol; 2003 Dec; 14(12):1722-6. PubMed ID: 14630675
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G; Benouaich-Amiel A; Diakite F; Taillibert S; Lejeune J; Laigle-Donadey F; Renard MA; Iraqi W; Idbaih A; Paris S; Capelle L; Duffau H; Cornu P; Simon JM; Mokhtari K; Polivka M; Omuro A; Carpentier A; Sanson M; Delattre JY; Hoang-Xuan K
Neurology; 2007 May; 68(21):1831-6. PubMed ID: 17515545
[TBL] [Abstract][Full Text] [Related]
20. Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review.
Hafazalla K; Sahgal A; Jaja B; Perry JR; Das S
Oncotarget; 2018 Sep; 9(72):33623-33633. PubMed ID: 30263090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
